Publications
Publications
- October 2014 (Revised July 2016)
- HBS Case Collection
Gilead: Hepatitis C Access Strategy (B)
Abstract
While the "Gilead: Hepatitis-C Access Strategy (A)" case (HBS No. 515-025) poses questions on what the company should do with respect to hard-hit countries like Egypt and India, the (B) case provides the answer. In both cases, the company chose to pursue a proactive strategy to enable access at affordable prices.
Keywords
Citation
Rangan, V. Kasturi. "Gilead: Hepatitis C Access Strategy (B)." Harvard Business School Supplement 515-044, October 2014. (Revised July 2016.)